Rear Spoiler Market worth over $5bn by 2024: Global Market Insights, Inc.
/
Date05 Jan 2018
Sellbyville, Delaware, Jan. 05, 2018 (GLOBE NEWSWIRE) — Rear Spoiler Market is expected to cross USD 5 billion by 2024; according to a new research... Read More →
BOURBON: Half-year liquidity contract statement contracted with CM CIC Market Solutions
/
Date05 Jan 2018
HALF-YEAR LIQUIDITY CONTRACT STATEMENT CONTRACTED WITH CM-CIC Market Solutions Under the liquidity contract signed between BOURBON CORPORATION and CM CIC Market Solutions, the following amounts... Read More →
Olympia Financial Group Inc. Announces January Dividend
/
Date05 Jan 2018
CALGARY, Alberta, Jan. 04, 2018 (GLOBE NEWSWIRE) — Olympia Financial Group Inc. (TSX:OLY) announces that its Board of Directors has declared a monthly cash dividend... Read More →
Aehr Test Systems Reports 88% Revenue Growth in Second Quarter of Fiscal 2018 and Reiterates Full Year Guidance
/
Date05 Jan 2018
FREMONT, Calif. , Jan. 04, 2018 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ:AEHR), a worldwide supplier of semiconductor test and burn-in equipment, today announced financial... Read More →
Brookfield Business Partners to Acquire Controlling Interest in Schoeller Allibert in Partnership With Schoeller Group
/
Date05 Jan 2018
BROOKFIELD, NEWS, Jan. 05, 2018 (GLOBE NEWSWIRE) — Brookfield Business Partners L.P. (NYSE:BBU) (TSX:BBU.UN) (“Brookfield Business Partners”), together with institutional partners (collectively “Brookfield”), announced today... Read More →
Chevron Fourth Quarter 2017 Earnings Conference Call
/
Date05 Jan 2018
San Ramon, CA, Jan. 04, 2018 (GLOBE NEWSWIRE) — Chevron Corporation (NYSE: CVX), one of the world’s leading energy companies, will hold its quarterly earnings... Read More →
Enhesa Announces the Increase in Global Jurisdiction Coverage to 286 in 2018, and Celebrates Being Named to CIO Review’s 20 Most Promising Compliance Technology Solution Providers
/
Date05 Jan 2018
Brussels, Belgium, Jan. 04, 2018 (GLOBE NEWSWIRE) — Enhesa, the leading global content provider focused on environmental, health and safety (EHS) regulatory compliance assurance support... Read More →
REGENXBIO Provides Year-End 2017 Corporate Update
/
Date05 Jan 2018
– Initiated third cohort dosing of RGX-314 Phase I clinical trial for wet AMD – – Initiated second cohort dosing of RGX-501 Phase I/II clinical... Read More →